Research - South San Francisco, California, United States
PrimeVax Immuno-Oncology, Inc. is developing the only one-time, one-week cancer treatment. We use a combination of the dengue fever virus and autologous dendritic cells to induce a strong immune response along with personalized tumor targeting.
Gmail
Google Tag Manager
Facebook Login (Connect)
Mobile Friendly
Google Cloud Hosting